Hikma stock gains 1.88 percent ahead of the open

At the close on September 24, 2026, Hikma stock stood at 1,625.00 pence after a 1.88 percent gain. The FTSE 100 fell 0.24 percent to 10,679.99 points, while a CFO appointment drove the session.

Hikma stock closed at 1,625.00 pence on the London Stock Exchange on September 24, 2026, up 1.88 percent. The shares outperformed the FTSE 100, which closed at 10,679.99 points, down 0.24 percent on the same session.

September 24, 2026 in numbers

Hikma Pharmaceuticals PLC (ISIN GB00B128J450) gained 30.00 pence from the previous close. Borsa Italiana reported that investors welcomed the appointment of Rebecca Hall as Hikma's next chief financial officer, effective in the first quarter of 2027.

The FTSE 100 lost 0.24 percent on September 24, 2026, leaving Hikma 2.12 percentage points ahead of the reference index. The market report gave Hikma's closing price and session change but did not provide a dated high, low or volume figure.

CFO appointment remains relevant today

Hikma enters the September 25, 2026 session with the leadership appointment as the latest company-specific development. TradingView carried the company announcement on September 24, 2026, identifying Hall as the incoming CFO.